Project Grant 2241912
Award Date
5/1/23
Completion Date
4/30/24
Dollars Obligated
$1M
Federal Agency
National Science Foundation
Awardee
Malcova Inc. (GSB6L7B1FB13)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Newark, CA 94560, USA
Similar Awards
This $305,000 National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) award supports the development of an innovative breast cancer screening technology by Bired Imaging Inc., a for-profit organization located in Rochester, NY. The project aims to improve early detection of breast cancer, especially in women with dense breast tissue, by using infrared imaging and physics-based AI algorithms to detect malignant...
This $175,000 National Science Foundation project grant supports the development of multi-modal soft tissue characterization technologies for non-invasive breast imaging at the University of Massachusetts Dartmouth from April 2022 through March 2024. Funded under the NSF's Computer and Information Science and Engineering program (CFDA 47.070), the research aims to establish optimization algorithms and parameters for visualizing breast tissue cross-sections non-invasively using an integrated...
This $673,366 Project Grant awarded by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) aims to develop a novel x-ray dual-energy cone-beam microCT (DECB microCT) imaging system dedicated to intraoperative imaging of lumpectomy specimens. The key goals are to enhance the contrast between breast cancer and normal fibroglandular tissues, enabling improved intraoperative identification of positive margins and reducing the high re-surgery rate in...
Bired Imaging Inc. received a $256,000 Small Business Innovation Research Phase I Project Grant from the National Science Foundation to develop an innovative breast cancer detection algorithm using infrared images. The 12-month project period runs from January 1, 2022 to December 31, 2022. The award is funded through the NSF's Directorate for Engineering, specifically its $47.041 million Engineering program. This program aims to improve quality of life and economic strength by fostering...
This $274,990 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports the development of a novel optical method for detecting microscopic tumors to enable more rapid and accurate point-of-care cancer diagnoses. The project aims to integrate plasmonic nanobubble sensors into a medical device platform and endoscope to perform minimally invasive, non-invasive cancer diagnostic procedures. The key product being...
This federal Project Grant award from the National Cancer Institute (NCI), funded under the Cancer Detection and Diagnosis Research program (CFDA 93.394), will deliver a 3D wearable Near-Infrared Spectral (NIRS) Tomography system for early prediction of residual cancer burden in breast cancer patients undergoing neoadjuvant chemotherapy. The $549,536.00 award to Trustees of Dartmouth College, awarded on July 10, 2024, will support the development and clinical validation of this innovative NIRS...
This $274,594 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports research and development of an innovative technology for cancer diagnosis and treatment. The project aims to improve molecular profiling and clinical laboratory testing of cancer samples by optimizing microdissection techniques. The research will focus on modeling and optimizing the opto-thermal-mechanical interactions involved in microdissection to...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Cerflux Inc. aims to develop a personalized cancer treatment screening platform. The project will establish guidelines for handling solid tumor biopsy samples, generate 3D bioprinted tumor models for validation, and demonstrate the platform's ability to match patients with the most effective cancer treatments before treatment begins. This innovative approach has the...
This $996,367 Cooperative Agreement award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development and productization of Lumo Imaging LLC's total body photography system and lesion classification software as a medical device for automatic detection of suspicious pigmented skin lesions. The two-year project aims to enable early-stage identification of skin cancers in primary care settings, addressing a...
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program (CFDA 47.084) provides $275,000 to Dcan Biosciences LLC to develop an advanced microfluidic system for cancer diagnosis and monitoring. The system aims to isolate and assess circulating tumor cells (CTCs) and CTC clusters (CTCCs) from patient blood samples to enable highly sensitive and accurate liquid biopsies. Key objectives include designing a hybrid microfluidic device for...